Evaluation of Hepatitis B Infection Prevalence in Institutionalized Intellectually Disabled Children
Novelty in Biomedicine,
Vol. 4 No. 2 (2016),
10 April 2016
,
Page 61-66
https://doi.org/10.22037/nbm.v4i2.8297
Abstract
Background: Hepatitis B virus (HBV) infection causes chronic infection in human population, with high mortality. One of the high risk communities is mentally retarded children, who are institutionalized. Special conditions in these centers predispose children for HBV infection and transmission to healthy people. In this study our objective was to determine the prevalence of HBV infection among institutionalized mentally retarded children and study its associated risk factors.Materials and Methods: In this study, 250 mentally retarded children (younger than 14 years old) were included. They were living in 5 nursing institutions, located in different parts of Tehran. Hepatitis B surface antigen (HBsAg) was measured in the sera of these patients by ELISA method.
Results: Among 250 children, 20 children (8%) were HBsAg positive. HBV infection in girls was more than boys (11% to 5.6%). Among the types of mental retardation, children with cerebral palsy had the highest positive result for HBsAg. The most HBV infection (28.5%) was seen in children with longest duration of being institutionalized (10 to 11 years). Vaccinated children were more HBsAg positive (8.7%) than non-vaccinated children (5.3%). However, no significant relationship was observed between any of these factors and HBsAg positivity.
Conclusion: Despite improvement of people’s health condition and implementation of HBV vaccination, the prevalence of HBV infection is increased in institutionalized mentally retarded children, which highlights the need for active measures to reduce this infection among this high risk population
- Hepatitis B virus
- Mentally retarded
- HBV vaccine
- intellectually disabled children
How to Cite
References
Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Iranian Med. 2000;3(4):192-201.
Maddrey W, Zohhi H. Hepatitis B: an important public health issue. J Med Virol. 2000;61(3):362-6.
Zuckerman A, Smithli h. More than third of world’s population has been infected with hepatitis B virus. BMJ. 1999;318(7192):12-3.
Sommer G, Heise T. Posttranscriptional control of HBV gene expression. j Bioscience. 2008;13:5533-47.
McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25(1):3-8.
Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6.
Asensio F, Bayas JM, Bertran MJ, Asenjo MA. Prevalence of hepatitis B infection in long-stay mentally handicapped adults. Euro J Epidemiol. 2000;16:725-9.
Souza MM, Barbosa MA, Tvares Borges AM, Daher RR, Bringel Martins RM, Paula Gardoso DD. Seroprevalence of hepatitis B virus infection in patients with mental problems. Rev Bras Psiquitr. 2004;26(1):34-7.
Perry E, Chaudhary R, Cleary TE, Roughley F. Hepatitis B surface antigen and its subtypes in an institution for the mentaly retarded. CMA. 1975;112(46):8-10.
Mesut A, Aylin S. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.hepatol. 2006;16(5): 201-6.
Supriya L, Nicola D. Investigation of Hepatitis B Virus and Human Immunodeficiency Virus Transmission among Severely Mentally Residents at a Long Term Care Facility. Hepatol. 2012;318(7192):12-3.
Sahebjamei M, Nik Bin B, Razavi Armaghani N. A comparison of HBsAg and HBsAb prevalence in patients with Down syndrome and other mentally retarded patients living in related children institutes in Tehran. J of Dent. 2003;16:725-9.
Hawkes R, Boughton C, Schroeter D. The antibody response of Institutionalized Down'S syndrome patients to seven microbial antigens. Immunol.1978 ;16(1):5-12.
Findor J, Sorda J, Rey J, Fernandez J. Hepatitis B (HBV) and C (HCV) virus infections in Downs syndrome and in neuropsychiatric patients without Downs syndrome. JGE.1992;46(3):208-12.
Scheutz F, Melbye M, Esteban JI, Aldershvile J, Ebessen P, Alter HJ. Hepatitis B virus infection in Danish dentists: A case-control and follow-up study. American Journal of Epidemiology 1998;128(1):190-6.
(16) Vellinga A, Van Damme p, Bruckers L, Weyler JJ, Molenberghs G, Meheus A. Modelling Long-Term Persistence of Hepatitis B Antibodies After Vaccination. J Med Virol. 1999;57:100-3.
Asensio F, Bayas JM, Bertran MJ, Asenjo MA. Prevalence of hepatitis B infection in long-stay mentally handicapped adults. Euro J Epidemiol. 2000;16:725-9.
Souza M, Barbosa M, Tvares Borges A. Seroprevalence of hepatitis B virus infection in patients with mental problems. Rev Bras Psiquitr. 2004;26(1):34-7.
Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat. 1998;5:17–23.
Vaezjalali M, Rezaee H, Goudarzi H, HBV S Gene Premature Stop Codon in Strains From Middle Eastern Patients. Arch Clin Infect Dis. 2013; 8(1): 3-7. DOI: 10.5812/archcid.14410
Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, et al. Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors. Hepat Mon. 2013;13(3):e6590. DOI: 10.5812/hepatmon.6590
Imani R, Karimi A, Rouzbahani R, Rouzbahani A. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Eastern Mediterr Health J. 2008;14(5): 1136-41.
Seyed Alinaghi SA, Kheirandish P, Karami N, Salem S, Shirzad H, Jahani MR, SeyedAhmadian MR, Valiollahi P, Hosseini M, Mohraz M, McFarland W. High prevalence of chronic hepatitis B infection among injection drug users in Iran: the need to increase vaccination of adults at risk.Acta Med Iran. 2010; 48(1): 58-60.
Nokhodian Z, Yaran M, Adibi P, Kassaian N, Meshkati M, Ataei B. Seroprevalence of hepatitis B markers among incarcerated intravenous drug users. Journal of Research in Medical Sciences. 2014;42(5):26-32.
Kandelouei T, Hosseini SM, Gachkar L, Keyvani H, Davoodbeglou F, Vaezjalali M. Reduction in Prevalence of Hepatitis B Surface Antigen Among Intravenous Drug Users in Tehran Drop-in-Centers. Arch Clin Infect Dis. 2013;8(2):2-8.
- Abstract Viewed: 482 times
- PDF Downloaded: 301 times